TrialCancer science2018

Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples.

Katsuyuki Kiura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.